MDL | MFCD00057374 |
---|---|
Molecular Weight | 261.09 |
Molecular Formula | C7H15Cl2N2O2P |
SMILES | ClCCN1P(OCCC1)(NCCCl)=O |
Ifosfamide is an alkylating chemotherapeutic agent with activity against a wide range of tumors.
DNA Alkylator [1]
Ifosfamide is an alkylating chemotherapeutic agent with activity against a wide range of tumors [1] . Ifosfamide is activated by the cytochrome P450 family. Ifosfamide (0-5 mM) suppresses the viability of CYP2B1-expressing C8III-1 cells, while it is cytotoxic to the non-CYP2B1-expressing CrFK cells only at high concentration (5 mM) [2] . CYP BM3 mutants activates Ifosfamide, and Ifosfamide shows inhibitory activity against human U2OS cells [3] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Ifosfamide (50 mg/kg, i.p.) treatment before mating increases percentage of post-implantation loss and resorbs fetuses in pregnant rats. Ifosfamide also (50 mg/kg, i.p.) decreases the progesterone in the serum of pregnant rats. However, Ifosfamide causes no obvious difference with the control rats at 25 mg/kg. Ifosfamide (25, 50 mg/kg, i.p.) induces apoptosis and histological changes in the placentas and prenatal rats, most sensitive fetal organs are the brain, liver and kidney [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
NCT Number | Sponsor | Condition | Start Date | Phase |
---|---|---|---|---|
NCT01102608 | Grupo Espanol de Investigacion en Sarcomas |
Soft Tissue Sarcoma
|
March 2008 | Phase 2 |
NCT00002526 | Swiss Group for Clinical Cancer Research |
Ovarian Cancer|Sarcoma
|
January 1993 | Phase 2 |
NCT00001300 | National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) |
Sarcoma
|
June 1992 | Phase 3 |
NCT00002566 | UNICANCER |
Extragonadal Germ Cell Tumor|Testicular Germ Cell Tumor
|
February 1994 | Phase 3 |
NCT00809341 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Genentech, Inc. |
Non-Hodgkin´s Lymphoma
|
January 2009 | Phase 2 |
NCT00324467 | British Columbia Cancer Agency|Hoffmann-La Roche |
Lymphoma, Non-Hodgkin|Advanced Stage Diffuse Large B-Cell Non-Hodgkin´s Lymphoma
|
August 2006 | Phase 2 |
NCT03643276 | Martin Schrappe|Deutsche Krebshilfe e.V., Bonn (Germany)|University Hospital Schleswig-Holstein |
Acute Lymphoblastic Leukemia, Pediatric
|
July 15, 2018 | Phase 3 |
NCT00007865 | University of Nebraska|National Cancer Institute (NCI) |
Lymphoma
|
September 2000 | Phase 2 |
NCT00002601 | City of Hope Medical Center|National Cancer Institute (NCI) |
Sarcoma
|
September 1994 | Phase 2 |
NCT00002516 | University Hospital Muenster|Medical Research Council|National Cancer Institute (NCI) |
Sarcoma
|
July 1992 | Phase 3 |
NCT00012311 | Herbert Irving Comprehensive Cancer Center|National Cancer Institute (NCI) |
Breast Cancer
|
January 2000 | Phase 2 |
NCT00134030 | Children´s Oncology Group|National Cancer Institute (NCI)|University College London Hospitals |
Localized Osteosarcoma|Metastatic Osteosarcoma
|
November 14, 2005 | Phase 3 |
NCT01055314 | National Cancer Institute (NCI) |
Adult Rhabdomyosarcoma|Childhood Alveolar Rhabdomyosarcoma|Childhood Embryonal Rhabdomyosarcoma|Metastatic Childhood Soft Tissue Sarcoma|Stage IV Adult Soft Tissue Sarcoma|Untreated Childhood Rhabdomyosarcoma
|
January 2010 | Phase 2 |
NCT00165139 | Dana-Farber Cancer Institute|Boston Children´s Hospital|Children´s Hospital of Philadelphia |
Neuroblastoma|Ewings Sarcoma|Non-rhabdomyosarcoma Soft Tissue Sarcoma
|
January 1996 | Phase 2 |
NCT03016871 | City of Hope Medical Center|National Cancer Institute (NCI) |
Recurrent Hodgkin Lymphoma|Refractory Hodgkin Lymphoma
|
April 24, 2017 | Phase 2 |
NCT00842595 | French Innovative Leukemia Organisation |
Diffuse Large B-Cell Lymphoma
|
December 2003 | Phase 2 |
NCT00662233 | Mayo Clinic|National Cancer Institute (NCI) |
Ovarian Cancer|Sarcoma
|
October 1991 | Early Phase 1 |
NCT00439361 | M.D. Anderson Cancer Center|Millennium Pharmaceuticals, Inc. |
Hodgkin Lymphoma|Lymphoma
|
February 2007 | Phase 1 |
NCT00004061 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) |
Leukemia|Lymphoma|Oral Complications
|
May 1999 | Phase 2 |
NCT00047320 | Children´s Oncology Group|National Cancer Institute (NCI) |
Brain Tumor|Central Nervous System Tumors|Childhood Germ Cell Tumor
|
January 2004 | Phase 2 |
NCT03628131 | Samsung Medical Center|Ministry of Health, Republic of Korea |
Relapsed Pediatric Solid Tumor|Refractory Pediatric Solid Tumor
|
October 2018 | Phase 1|Phase 2 |
NCT00280878 | Bayside Health |
Non-Hodgkin´s Lymphoma (CD20&addition;)
|
January 2006 | Phase 2 |
NCT00598169 | AIDS Malignancy Consortium|National Cancer Institute (NCI)|The Emmes Company, LLC |
Lymphoma
|
November 2007 | Phase 1 |
NCT00002804 | Children´s Oncology Group|National Cancer Institute (NCI) |
Sarcoma
|
September 1996 | Phase 2 |
NCT00002791 | Radiation Therapy Oncology Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group |
Sarcoma
|
February 1997 | Phase 2 |
NCT00045461 | Ludwig-Maximilians - University of Munich|National Cancer Institute (NCI) |
Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer
|
June 2000 | Phase 2|Phase 3 |
NCT00199056 | Johann Wolfgang Goethe University Hospital |
Adult Acute Lymphocytic Leukemia
|
October 1999 | Phase 4 |
NCT00061984 | European Organisation for Research and Treatment of Cancer - EORTC |
Sarcoma
|
April 2003 | Phase 3 |
NCT00058461 | National Cancer Institute (NCI) |
B-cell Childhood Acute Lymphoblastic Leukemia|Childhood Burkitt Lymphoma|Childhood Diffuse Large Cell Lymphoma|Childhood Immunoblastic Large Cell Lymphoma|L3 Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Large Cell Lymphoma|Recurrent Childhood Lymphoblastic Lymphoma|Recurrent Childhood Small Noncleaved Cell Lymphoma
|
November 2003 | Phase 2 |
NCT00002494 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) |
Leukemia|Lymphoma
|
May 1992 | Phase 2 |
NCT00293358 | Children´s Cancer and Leukaemia Group|National Cancer Institute (NCI) |
Brain and Central Nervous System Tumors
|
January 1997 | Phase 3 |
NCT02812654 | AC Camargo Cancer Center |
Sarcoma, Soft Tissue
|
March 2015 | Phase 2 |
NCT04581265 | Sun Yat-sen University |
Extracranial Germ Cell Tumor, Pediatric
|
November 10, 2020 | Phase 2 |
NCT00002466 | Memorial Sloan Kettering Cancer Center |
Kidney Cancer|Sarcoma
|
May 1990 | Phase 2 |
NCT00025363 | National Cancer Institute (NCI) |
Alveolar Childhood Rhabdomyosarcoma|Embryonal Childhood Rhabdomyosarcoma|Embryonal-botryoid Childhood Rhabdomyosarcoma|Previously Treated Childhood Rhabdomyosarcoma|Recurrent Childhood Rhabdomyosarcoma
|
November 2001 | Phase 2 |
NCT01979536 | National Cancer Institute (NCI) |
Anaplastic Large Cell Lymphoma, ALK-Positive|Ann Arbor Stage II Noncutaneous Childhood Anaplastic Large Cell Lymphoma|Ann Arbor Stage III Noncutaneous Childhood Anaplastic Large Cell Lymphoma|Ann Arbor Stage IV Noncutaneous Childhood Anaplastic Large Cell Lymphoma
|
November 8, 2013 | Phase 2 |
NCT00544778 | City of Hope Medical Center|National Cancer Institute (NCI) |
Sarcoma
|
August 2001 | Phase 2 |
NCT00003105 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) |
Bladder Cancer|Transitional Cell Cancer of the Renal Pelvis and Ureter
|
September 1997 | Phase 1|Phase 2 |
NCT00788125 | City of Hope Medical Center|National Cancer Institute (NCI) |
Brain and Central Nervous System Tumors|Childhood Germ Cell Tumor|Extragonadal Germ Cell Tumor|Kidney Cancer|Liver Cancer|Lymphoma|Neuroblastoma|Ovarian Cancer|Sarcoma|Testicular Germ Cell Tumor|Unspecified Childhood Solid Tumor, Protocol Specific
|
September 3, 2008 | Phase 1|Phase 2 |
NCT01490060 | M.D. Anderson Cancer Center|Merck Sharp & Dohme LLC |
Sarcoma|Chemotherapy-induced Nausea and Vomiting|Effects of Chemotherapy|Adverse Effects of Medical Drugs
|
May 2012 | Not Applicable |
NCT00003292 | Southwest Oncology Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group |
Chondrosarcoma|Adult Fibrosarcoma|Adult Leiomyosarcoma|Adult Rhabdomyosarcoma|Adult Malignant Meningioma|Adult Brain Malignant Hemangiopericytoma
|
July 1998 | Phase 2 |
NCT00960063 | Merck Sharp & Dohme LLC |
Neoplasms|Solid Tumors|Bone Cancer|Kidney Tumor|Neuroblastoma
|
November 11, 2009 | Phase 1 |
NCT00512096 | M.D. Anderson Cancer Center |
Penile Cancer
|
August 1999 | Phase 2 |
NCT05221645 | University of Southampton|Merck Sharp & Dohme LLC |
Diffuse Large B Cell Lymphoma
|
June 27, 2022 | Phase 2 |
NCT00002558 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) |
Extragonadal Germ Cell Tumor|Ovarian Cancer|Testicular Germ Cell Tumor
|
January 1994 | Phase 1|Phase 2 |
NCT00004172 | Northwestern University|National Cancer Institute (NCI) |
Breast Cancer
|
October 1999 | Phase 2 |
NCT04968106 | Institut Bergonié|Incyte Biosciences International Sàrl |
Resectable Sarcoma
|
March 23, 2022 | Phase 2 |
NCT03064867 | Molly Gallogly|Case Comprehensive Cancer Center |
Diffuse Large B-cell-lymphoma
|
June 26, 2017 | Phase 1|Phase 2 |
NCT00002898 | Societe Internationale d´Oncologie Pediatrique|National Cancer Institute (NCI) |
Childhood Malignant Fibrous Histiocytoma of Bone|Sarcoma
|
January 1995 | Phase 3 |
NCT00613457 | Associazione Italiana Ematologia Oncologia Pediatrica |
Leukemia
|
September 2000 | Phase 3 |
NCT00974792 | Cancer Research UK|National Cancer Institute (NCI) |
Lymphoma
|
January 2006 | Phase 2 |
NCT04126811 | Tianjin Medical University Cancer Institute and Hospital |
Soft Tissue Sarcoma
|
June 1, 2019 | Phase 2 |
NCT00430118 | University Hospital Schleswig-Holstein |
Leukemia
|
July 2000 | Phase 3 |
NCT02771743 | Samsung Medical Center |
Newly Diagnosed High Risk Neuroblastoma
|
April 2015 | Phase 2 |
NCT04322318 | Children´s Oncology Group|National Cancer Institute (NCI) |
Anaplastic Kidney Wilms Tumor|Recurrent Kidney Wilms Tumor|Stage II Kidney Wilms Tumor|Stage III Kidney Wilms Tumor|Stage IV Kidney Wilms Tumor
|
September 18, 2020 | Phase 2 |
NCT01873326 | Memorial Sloan Kettering Cancer Center|University of Southern California|Mayo Clinic|University of Pittsburgh|University of North Carolina|University of Chicago|Stanford University|University of Texas Southwestern Medical Center |
Germ Cell Tumors
|
June 2013 | Phase 2 |
NCT00470223 | UNICANCER|Novartis|Chugai Pharmaceutical|National Cancer Institute, France|SFCE|Ligue contre le cancer, France |
Sarcoma
|
March 2007 | Phase 3 |
NCT00072280 | Children´s Oncology Group|National Cancer Institute (NCI) |
Sarcoma
|
November 2004 | Phase 2 |
NCT04776525 | Oslo University Hospital|Haukeland University Hospital |
Soft Tissue Sarcoma
|
April 27, 2021 | Phase 2 |
NCT03277924 | Grupo Espanol de Investigacion en Sarcomas |
Soft Tissue Sarcoma|Bone Sarcoma
|
May 31, 2017 | Phase 1|Phase 2 |
NCT00255723 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) |
Lymphoma
|
April 2004 | Phase 2 |
NCT00006760 | Children´s Oncology Group|National Cancer Institute (NCI) |
Lymphoma
|
May 2001 | Phase 2 |
NCT00822848 | OHSU Knight Cancer Institute|National Cancer Institute (NCI) |
Sarcoma
|
February 2009 | Phase 1 |
NCT00093509 | Mark Dewhirst|National Cancer Institute (NCI)|Duke University |
Sarcoma
|
November 1999 | Phase 1|Phase 2 |
NCT00003631 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) |
Lymphoma
|
August 1998 | Phase 2 |
NCT00193505 | SCRI Development Innovations, LLC|Biogen |
Non-Hodgkins Lymphoma
|
October 2003 | Phase 2 |
NCT00231842 | Montefiore Medical Center |
Uterine Cancer
|
February 2003 | Phase 2 |
NCT04690231 | Peking University People´s Hospital|Peking University Shougang Hospital |
Effect of Drug|Toxicity, Drug|Secondary Resistance
|
December 1, 2020 | Not Applicable |
NCT00077285 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) |
Sarcoma
|
October 2003 | Phase 2 |
NCT00289809 | Istituto Clinico Humanitas |
Sarcoma, Soft Tissue
|
September 2006 | Phase 1|Phase 2 |
NCT00025441 | Societe Internationale d´Oncologie Pediatrique|Children´s Cancer and Leukaemia Group|Societe Francaise Oncologie Pediatrique|National Cancer Institute (NCI) |
Ovarian Cancer|Sarcoma|Small Intestine Cancer
|
November 1998 | Phase 2 |
NCT00002565 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) |
Lymphoma
|
May 25, 1994 | Phase 3 |
NCT00002835 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) |
Lymphoma
|
October 30, 1995 | Phase 3 |
NCT00003159 | Medical Research Council|European Organisation for Research and Treatment of Cancer - EORTC|National Cancer Institute (NCI) |
Lung Cancer
|
August 1997 | Phase 3 |
NCT00381940 | National Cancer Institute (NCI) |
Adult Lymphocyte Depletion Hodgkin Lymphoma|Adult Lymphocyte Predominant Hodgkin Lymphoma|Adult Mixed Cellularity Hodgkin Lymphoma|Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma|Adult Nodular Sclerosis Hodgkin Lymphoma|Childhood Lymphocyte Depletion Hodgkin Lymphoma|Childhood Lymphocyte Predominant Hodgkin Lymphoma|Childhood Mixed Cellularity Hodgkin Lymphoma|Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma|Childhood Nodular Sclerosis Hodgkin Lymphoma|Recurrent Adult Hodgkin Lymphoma|Recurrent+Refractory Childhood Hodgkin Lymphoma|Stage I Adult Hodgkin Lymphoma|Stage I Childhood Hodgkin Lymphoma|Stage II Adult Hodgkin Lymphoma|Stage II Childhood Hodgkin Lymphoma|Stage III Adult Hodgkin Lymphoma|Stage III Childhood Hodgkin Lymphoma|Stage IV Adult Hodgkin Lymphoma|Stage IV Childhood Hodgkin Lymphoma
|
January 2007 | Phase 2 |
NCT01795430 | City of Hope Medical Center|National Cancer Institute (NCI) |
Adult Supratentorial Primitive Neuroectodermal Tumor (PNET)|Ewing Sarcoma of Bone|Extraosseous Ewing Sarcoma|Metastatic Ewing Sarcoma+Peripheral Primitive Neuroectodermal Tumor|Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor|Recurrent Ewing Sarcoma+Peripheral Primitive Neuroectodermal Tumor|Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
|
July 2013 | Not Applicable |
NCT00004916 | Northwestern University|National Cancer Institute (NCI) |
Lymphoma
|
February 1999 | Phase 1|Phase 2 |
NCT04981899 | St. Petersburg State Pavlov Medical University |
Hodgkin Lymphoma
|
March 1, 2021 | Phase 1|Phase 2 |
NCT02099175 | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano|Regione Lombardia |
Sinonasal Tumors
|
November 2013 | Phase 2 |
NCT02432274 | Eisai Limited|Merck Sharp & Dohme LLC|Eisai Inc. |
Tumors|Solid Malignant Tumors|Osteosarcoma|Differentiated Thyroid Cancer (DTC)
|
December 29, 2014 | Phase 1|Phase 2 |
NCT00028860 | Tulane University Health Sciences Center|National Cancer Institute (NCI) |
Bladder Cancer|Transitional Cell Cancer of the Renal Pelvis and Ureter
|
October 2001 | Phase 2 |
NCT00003575 | National Cancer Institute (NCI) |
Lymphoma
|
January 1999 | Phase 2 |
NCT04224337 | Seoul National University Hospital |
Carcinoma, Non-Small-Cell Lung
|
June 11, 2020 | Phase 2 |
NCT04475016 | Sun Yat-sen University |
Penile Cancer
|
August 12, 2020 | Phase 2 |
NCT00002764 | European Organisation for Research and Treatment of Cancer - EORTC|Eastern Cooperative Oncology Group|Scandinavian Sarcoma Group|Southwest Oncology Group |
Endometrial Cancer|Kidney Cancer|Metastatic Cancer|Ovarian Cancer|Pheochromocytoma|Sarcoma
|
April 1996 | Phase 3 |
NCT00231582 | Assistance Publique - Hôpitaux de Paris|Ministry of Health, France|Amgen|Baxter Healthcare Corporation |
Testicular Neoplasms
|
September 2004 | Phase 2 |
NCT00450801 | University of Miami |
Lymphoma
|
April 2004 | Phase 2 |
NCT00003541 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) |
Lymphoma
|
June 1998 | Phase 1|Phase 2 |
NCT03071822 | The University of Hong Kong |
Peripheral T Cell Lymphoma
|
February 24, 2017 | Phase 4 |
NCT04684368 | Children´s Oncology Group|National Cancer Institute (NCI) |
Central Nervous System Nongerminomatous Germ Cell Tumor|Choriocarcinoma|Embryonal Carcinoma|Immature Teratoma|Malignant Teratoma|Mixed Germ Cell Tumor|Pineal Region Germ Cell Tumor|Pineal Region Immature Teratoma|Pineal Region Yolk Sac Tumor|Suprasellar Germ Cell Tumor
|
June 4, 2021 | Phase 2 |
NCT01026220 | Children´s Oncology Group|National Cancer Institute (NCI) |
Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma|Stage III Childhood Hodgkin Lymphoma|Stage IV Childhood Hodgkin Lymphoma
|
December 7, 2009 | Phase 3 |
NCT00829205 | Cancer Research UK|National Cancer Institute (NCI) |
Lymphoma
|
January 2009 | Phase 1|Phase 2 |
NCT02471911 | Weill Medical College of Cornell University|Karyopharm Therapeutics Inc|The Leukemia and Lymphoma Society|FDA Office of Orphan Products Development |
Diffuse Large B-Cell Lymphoma
|
December 11, 2015 | Phase 1 |
NCT00245011 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|National Cancer Institute (NCI) |
Sarcoma
|
October 2004 | Phase 2 |
NCT00658580 | European Lung Cancer Working Party |
Small Cell Lung Carcinoma, Extensive Disease
|
April 2000 | Phase 3 |
NCT00317408 | European Inter-group Cooperation on Childhood and Adolescent Non Hodgkin Lymphoma|National Cancer Institute (NCI) |
Lymphoma
|
April 2004 | Not Applicable |
NCT00003284 | Herbert Irving Comprehensive Cancer Center|National Cancer Institute (NCI) |
Lung Cancer
|
January 1998 | Phase 2 |
NCT00148395 | Aktion Bronchialkarzinom e.V. |
Non-Small-Cell Lung Carcinoma
|
June 2002 | Phase 3 |
NCT00967291 | IRCCS San Raffaele |
Pancreatic Cancer
|
March 2006 | Phase 2 |
NCT01169636 | M.D. Anderson Cancer Center|Novartis |
Hodgkin´s Lymphoma
|
January 31, 2011 | Phase 1|Phase 2 |
NCT01231906 | Children´s Oncology Group|National Cancer Institute (NCI) |
Localized Extraskeletal Ewing Sarcoma|Peripheral Primitive Neuroectodermal Tumor of Bone|Peripheral Primitive Neuroectodermal Tumor of Soft Tissues
|
November 22, 2010 | Phase 3 |
NCT01872416 | The First Affiliated Hospital of Guangzhou Medical University |
Small Cell Lung Cancer
|
October 2012 | Phase 2 |
NCT00392834 | AIDS Malignancy Consortium|National Cancer Institute (NCI)|The Emmes Company, LLC |
Lymphoma
|
September 2006 | Phase 2 |
NCT00645632 | Mayo Clinic|National Cancer Institute (NCI) |
Sarcoma
|
November 1990 | Not Applicable |
NCT02219737 | National Cancer Institute (NCI) |
CD20 Positive|Recurrent Diffuse Large B-Cell Lymphoma|Refractory Diffuse Large B-Cell Lymphoma
|
September 12, 2014 | Phase 1 |
NCT02393859 | Amgen |
Leukemia, Acute Lymphoblastic
|
November 10, 2015 | Phase 3 |
NCT00199082 | Nicola Goekbuget|Goethe University |
Burkitt´s Lymphoma|Burkitt´s Leukemia|Mediastinal Neoplasms|Lymphoblastic Lymphoma|Large Cell Anaplastic Lymphoma
|
July 2002 | Phase 4 |
NCT00137995 | Lymphoma Study Association |
Lymphoma, Large-Cell, Diffuse
|
June 2003 | Phase 3 |
NCT00003852 | UNICANCER |
Childhood Germ Cell Tumor|Extragonadal Germ Cell Tumor|Ovarian Cancer|Testicular Germ Cell Tumor
|
March 1998 | Phase 2 |
NCT00410631 | Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany|National Cancer Institute (NCI) |
Neuroblastoma
|
October 2004 | Phase 3 |
NCT02306161 | National Cancer Institute (NCI) |
Metastatic Ewing Sarcoma|Metastatic Malignant Neoplasm in the Bone|Metastatic Malignant Neoplasm in the Bone Marrow|Metastatic Malignant Neoplasm in the Lung|Metastatic Peripheral Primitive Neuroectodermal Tumor of Bone|Peripheral Primitive Neuroectodermal Tumor of Soft Tissues
|
December 8, 2014 | Phase 3 |
NCT00017368 | Children´s Oncology Group|National Cancer Institute (NCI) |
Neuroblastoma
|
April 2001 | Phase 2 |
NCT00302003 | Children´s Oncology Group|National Cancer Institute (NCI) |
Childhood Favorable Prognosis Hodgkin Lymphoma|Childhood Lymphocyte Depletion Hodgkin Lymphoma|Childhood Mixed Cellularity Hodgkin Lymphoma|Childhood Nodular Sclerosis Hodgkin Lymphoma|Stage I Childhood Hodgkin Lymphoma|Stage II Childhood Hodgkin Lymphoma
|
February 2006 | Phase 3 |
NCT01424839 | University Hospital Muenster|Deutsche Kinderkrebsstiftung|Hannover Medical School|Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany |
Intracranial Germ Cell Tumors
|
October 2011 | Phase 4 |
NCT00304083 | Sarcoma Alliance for Research through Collaboration|National Cancer Institute (NCI) |
Neurofibromatosis Type 1|Sarcoma
|
December 2005 | Phase 2 |
NCT04043494 | University Hospital Muenster|Deutsche Krebshilfe e.V., Bonn (Germany) |
Lymphoblastic Lymphoma, Childhood
|
August 23, 2019 | Phase 3 |
NCT00346164 | Children´s Oncology Group|National Cancer Institute (NCI) |
Adult Alveolar Soft-part Sarcoma|Adult Angiosarcoma|Adult Epithelioid Sarcoma|Adult Extraskeletal Chondrosarcoma|Adult Extraskeletal Osteosarcoma|Adult Fibrosarcoma|Adult Leiomyosarcoma|Adult Liposarcoma|Adult Malignant Fibrous Histiocytoma|Adult Malignant Hemangiopericytoma|Adult Malignant Mesenchymoma|Adult Neurofibrosarcoma|Adult Synovial Sarcoma|Childhood Alveolar Soft-part Sarcoma|Childhood Angiosarcoma|Childhood Epithelioid Sarcoma|Childhood Fibrosarcoma|Childhood Leiomyosarcoma|Childhood Liposarcoma|Childhood Malignant Mesenchymoma|Childhood Neurofibrosarcoma|Childhood Synovial Sarcoma|Dermatofibrosarcoma Protuberans|Metastatic Childhood Soft Tissue Sarcoma|Nonmetastatic Childhood Soft Tissue Sarcoma|Stage I Adult Soft Tissue Sarcoma|Stage II Adult Soft Tissue Sarcoma|Stage III Adult Soft Tissue Sarcoma|Stage IV Adult Soft Tissue Sarcoma
|
February 5, 2007 | Phase 3 |
NCT01946529 | St. Jude Children´s Research Hospital|University of Tennessee Health Science Center|University of Florida|Nemours Children´s Clinic |
Desmoplastic Small Round Cell Tumor|Ewing Sarcoma of Bone or Soft Tissue|Localized Ewing Sarcoma+Peripheral Primitive Neuroectodermal Tumor|Metastatic Ewing Sarcoma+Peripheral Primitive Neuroectodermal Tumor
|
December 27, 2013 | Phase 2 |
NCT03623087 | The University of Hong Kong |
Non-Hodgkin´s Lymphoma, Relapsed|Non-Hodgkin T-cell Lymphoma|Natural Killer+T-Cell Lymphoma, Nasal and Nasal-Type
|
July 1, 2017 | Phase 3 |
NCT00023738 | Radiation Therapy Oncology Group|National Cancer Institute (NCI) |
Sarcoma
|
August 2001 | Phase 1|Phase 2 |
NCT00920153 | French Innovative Leukemia Organisation |
Lymphoma
|
May 2008 | Phase 3 |
NCT01097057 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) |
Non-Hodgkin Lymphoma
|
November 9, 2010 | Phase 2 |
NCT01329900 | M.D. Anderson Cancer Center|Novartis |
Lymphoma
|
August 22, 2011 | Phase 2 |
NCT02628405 | Academic and Community Cancer Research United|National Cancer Institute (NCI) |
Recurrent B-Cell Non-Hodgkin Lymphoma|Recurrent Diffuse Large B-Cell Lymphoma|Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma|Recurrent Transformed Non-Hodgkin Lymphoma|Refractory B-Cell Non-Hodgkin Lymphoma|Refractory Diffuse Large B-Cell Lymphoma|Refractory Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma|Refractory Transformed Non-Hodgkin Lymphoma
|
May 20, 2016 | Phase 1|Phase 2 |
NCT00673179 | M.D. Anderson Cancer Center |
Osteosarcoma
|
May 2008 | Not Applicable |
NCT04189952 | University of Miami|AstraZeneca |
Diffuse Large B Cell Lymphoma|Chronic Lymphocytic Leukemia|Small Lymphocytic Leukemia|Marginal Zone Lymphoma
|
September 22, 2020 | Phase 2 |
NCT00003657 | Dana-Farber Cancer Institute|National Cancer Institute (NCI) |
Bladder Cancer|Brain and Central Nervous System Tumors|Carcinoma of Unknown Primary|Extragonadal Germ Cell Tumor|Head and Neck Cancer|Kidney Cancer|Lung Cancer|Ovarian Cancer|Sarcoma|Testicular Germ Cell Tumor|Unspecified Adult Solid Tumor, Protocol Specific
|
July 1998 | Phase 2 |
NCT01602666 | Children´s Oncology Group|National Cancer Institute (NCI) |
Central Nervous System Nongerminomatous Germ Cell Tumor|Childhood Central Nervous System Germinoma
|
May 29, 2012 | Phase 2 |
NCT03458260 | The Lymphoma Academic Research Organisation |
Aggressive Non-Hodgkin Lymphoma
|
March 26, 2018 | Phase 2 |
NCT00551122 | University of Southampton|University Hospital Southampton NHS Foundation Trust |
Brain and Central Nervous System Tumors|Extragonadal Germ Cell Tumor|Ovarian Cancer|Testicular Germ Cell Tumor
|
November 2006 | Phase 1|Phase 2 |
NCT00864318 | Institut Claudius Regaud |
Germ Cell Tumors
|
March 13, 2009 | Phase 2 |
NCT01746992 | Ruijin Hospital |
ALK-negative Anaplastic Large Cell Lymphoma|Peripherial T Cell Lymphoma,Not Otherwise Specified|Angioimmunoblastic T Cell Lymphoma|Enteropathy Associated T Cell Lymphoma|Hepatosplenic T Cell Lymphoma|Subcutaneous Panniculitis Like T Cell Lymphoma
|
September 2012 | Phase 4 |
NCT01884428 | Armando Santoro, MD|Istituto Clinico Humanitas |
Hodgkin´s Lymphoma
|
July 2011 | Phase 1 |
NCT00623077 | Masonic Cancer Center, University of Minnesota |
Brain and Central Nervous System Tumors|Kidney Cancer|Liver Cancer|Retinoblastoma|Sarcoma
|
August 2005 | Phase 1 |
NCT00002546 | Gynecologic Oncology Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group|GOG Foundation |
Sarcoma
|
December 1993 | Phase 3 |
NCT03418038 | Mayo Clinic|National Cancer Institute (NCI) |
Clonal Cytopenia of Undetermined Significance|High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements|Recurrent Diffuse Large B-Cell Lymphoma|Recurrent Hodgkin Lymphoma|Recurrent Lymphoma|Refractory Diffuse Large B-Cell Lymphoma|Refractory Lymphoma
|
March 23, 2018 | Phase 2 |
NCT00764907 | University Hospital, Motol|National Cancer Institute (NCI) |
Leukemia
|
November 2002 | Phase 3 |
NCT00006455 | Gustave Roussy, Cancer Campus, Grand Paris |
Lymphoma
|
November 26, 1999 | Phase 3 |
NCT00017225 | Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany|National Cancer Institute (NCI) |
Neuroblastoma
|
May 1997 | Phase 2 |
NCT00147225 | M.D. Anderson Cancer Center|Amgen |
Solid Tumors|Advanced Cancer
|
August 2005 | Phase 1|Phase 2 |
NCT00667342 | St. Jude Children´s Research Hospital|Genentech, Inc. |
Osteosarcoma|Malignant Fibrous Histiocytoma (MFH) of Bone
|
June 3, 2008 | Phase 2 |
NCT00018954 | National Institutes of Health Clinical Center (CC)|National Cancer Institute (NCI) |
Leukemia|Lymphoma
|
October 1992 | Phase 2 |
NCT03007147 | Children´s Oncology Group|National Cancer Institute (NCI) |
Acute Lymphoblastic Leukemia|B Acute Lymphoblastic Leukemia|Mixed Phenotype Acute Leukemia|T Acute Lymphoblastic Leukemia
|
July 28, 2017 | Phase 3 |
NCT02050919 | OHSU Knight Cancer Institute|Bayer|Oregon Health and Science University |
Pleomorphic Rhabdomyosarcoma|Stage IIB Adult Soft Tissue Sarcoma AJCC v7|Stage III Adult Soft Tissue Sarcoma AJCC v7|Stage IV Adult Soft Tissue Sarcoma AJCC v7
|
December 3, 2013 | Phase 2 |
NCT02638428 | Samsung Medical Center|Ministry of Health, Republic of Korea |
Relapsed Pediatric Solid Tumor|Refractory Pediatric Solid Tumor|Relapsed Pediatric AML|Refractory Pediatric AML
|
December 2015 | Phase 2 |
NCT00541411 | King Faisal Specialist Hospital & Research Center |
Ewing´s Sarcoma
|
June 2003 | Not Applicable |
NCT00072215 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) |
Extragonadal Germ Cell Tumor|Testicular Germ Cell Tumor
|
April 2004 | Phase 3 |
NCT02112916 | National Cancer Institute (NCI) |
Adult T Acute Lymphoblastic Leukemia|Ann Arbor Stage II Adult Lymphoblastic Lymphoma|Ann Arbor Stage II Childhood Lymphoblastic Lymphoma|Ann Arbor Stage III Adult Lymphoblastic Lymphoma|Ann Arbor Stage III Childhood Lymphoblastic Lymphoma|Ann Arbor Stage IV Adult Lymphoblastic Lymphoma|Ann Arbor Stage IV Childhood Lymphoblastic Lymphoma|Childhood T Acute Lymphoblastic Leukemia
|
September 30, 2014 | Phase 3 |
NCT00574496 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) |
Lymphoma
|
November 13, 2007 | Phase 2 |
NCT01505569 | Masonic Cancer Center, University of Minnesota |
Ewing´s Family Tumors|Renal Tumors|Hepatoblastoma|Rhabdomyosarcoma|Soft Tissue Sarcoma|Primary Malignant Brain Neoplasms|Retinoblastoma|Medulloblastoma|Supra-tentorial Primative Neuro-Ectodermal Tumor (PNET)|Atypical Teratoid+Rhabdoid Tumor (AT+RT)|CNS Tumors|Germ Cell Tumors
|
October 20, 2011 | Not Applicable |
NCT00002931 | City of Hope Medical Center|National Cancer Institute (NCI) |
Brain and Central Nervous System Tumors|Extragonadal Germ Cell Tumor|Ovarian Cancer|Teratoma|Testicular Germ Cell Tumor
|
February 1997 | Phase 2 |
NCT00005631 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) |
Lymphoma
|
November 1999 | Phase 2 |
NCT00012051 | Commissie Voor Klinisch Toegepast Onderzoek|National Cancer Institute (NCI) |
Lymphoma
|
September 2000 | Phase 3 |
NCT00002816 | Children´s Oncology Group|National Cancer Institute (NCI) |
Leukemia
|
December 1996 | Phase 3 |
NCT04625907 | University of Birmingham |
Rhabdomyosarcoma
|
September 17, 2020 | Phase 1|Phase 2 |
NCT01959698 | Roswell Park Cancer Institute|National Cancer Institute (NCI)|Amgen |
CD20 Positive|Recurrent Diffuse Large B-Cell Lymphoma|Refractory Diffuse Large B-Cell Lymphoma|Stage I Diffuse Large B-Cell Lymphoma|Stage II Diffuse Large B-Cell Lymphoma|Stage III Diffuse Large B-Cell Lymphoma|Stage IV Diffuse Large B-Cell Lymphoma
|
April 17, 2014 | Phase 1 |
NCT00001209 | National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) |
Neuroectodermal Tumor, Primitive|Neuroepithelioma|Osteosarcoma|Sarcoma|Sarcoma, Ewing´s
|
October 1986 | Phase 1 |
NCT04221035 | Gustave Roussy, Cancer Campus, Grand Paris |
High-Risk Neuroblastoma
|
November 5, 2019 | Phase 3 |
NCT00002524 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) |
Lymphoma
|
June 1993 | Phase 2 |
NCT00002865 | Wake Forest University Health Sciences|National Cancer Institute (NCI) |
Leukemia
|
April 1995 | Phase 2 |
NCT00006260 | Case Comprehensive Cancer Center|National Cancer Institute (NCI) |
Breast Cancer
|
May 1997 | Phase 2 |
NCT02375204 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI)|European Organisation for Research and Treatment of Cancer - EORTC|Movember Foundation|Institute of Cancer Research (ICR), United Kingdom|Cancer Research UK|UNICANCER|Irish Group CTI |
Germ Cell Tumor|Teratoma|Choriocarcinoma|Germinoma|Mixed Germ Cell Tumor|Yolk Sac Tumor|Childhood Teratoma|Malignant Germ Cell Neoplasm|Extragonadal Seminoma|Non-seminomatous Germ Cell Tumor|Seminoma
|
March 2015 | Phase 3 |
NCT00003128 | Gynecologic Oncology Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group|GOG Foundation |
Sarcoma
|
November 1997 | Phase 3 |
NCT00504751 | Weill Medical College of Cornell University|Millennium Pharmaceuticals, Inc. |
Non-Hodgkin´s Lymphoma
|
May 2007 | Phase 2 |
NCT00026078 | Grupo Oncologico Cooperativo del Sur|National Cancer Institute (NCI) |
Breast Cancer
|
March 2001 | Phase 2 |
NCT00004086 | Garden State Cancer Center at the Center for Molecular Medicine and Immunology|National Cancer Institute (NCI) |
Leukemia|Lymphoma
|
June 1997 | Phase 1 |
NCT02414685 | National Cancer Institute, Slovakia |
Germ Cell Tumor
|
April 2015 | Phase 2 |
NCT00011921 | EBMT Solid Tumors Working Party|National Cancer Institute (NCI) |
Lung Cancer
|
September 1997 | Phase 3 |
NCT01446809 | University of Washington|National Cancer Institute (NCI) |
Stage IIA Adult Soft Tissue Sarcoma|Stage III Adult Soft Tissue Sarcoma|Stage IV Adult Soft Tissue Sarcoma
|
April 2012 | Not Applicable |
NCT02106988 | M.D. Anderson Cancer Center |
Lymphoma
|
January 16, 2015 | Phase 2 |
NCT00173862 | National Taiwan University Hospital |
Transitional Cell Carcinoma
|
May 2000 | Phase 2 |
NCT02592876 | Seagen Inc. |
Lymphoma, B-cell|Lymphoma, Large B-Cell, Diffuse|Lymphoma, Follicular, Grade 3b|Follicular Lymphoma, Grade 3b
|
October 2015 | Phase 2 |
NCT00004077 | Medical Research Council|National Cancer Institute (NCI) |
Testicular Germ Cell Tumor
|
May 1996 | Phase 2 |
NCT00086970 | National Cancer Institute (NCI) |
Unspecified Adult Solid Tumor, Protocol Specific
|
June 2004 | Phase 1 |
NCT00712582 | Memorial Sloan Kettering Cancer Center|Genentech, Inc.|Columbia University |
Non-Hodgkin´s Lymphoma
|
July 1, 2008 | Phase 2 |
NCT00967369 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) |
Recurrent Classic Hodgkin Lymphoma|Refractory Classic Hodgkin Lymphoma
|
August 24, 2009 | Phase 2 |
NCT00002641 | European Organisation for Research and Treatment of Cancer - EORTC|NCIC Clinical Trials Group |
Endometrial Cancer|Kidney Cancer|Ovarian Cancer|Pheochromocytoma|Sarcoma
|
February 1995 | Phase 3 |
NCT04665765 | City of Hope Medical Center|National Cancer Institute (NCI) |
Diffuse Large B-Cell Lymphoma Unclassifiable|Recurrent Diffuse Large B-Cell Lymphoma|Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma|Recurrent Transformed B-Cell Non-Hodgkin Lymphoma|Refractory Diffuse Large B-Cell Lymphoma|Refractory Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma|Refractory Transformed B-Cell Non-Hodgkin Lymphoma
|
January 18, 2021 | Phase 2 |
NCT00954174 | GOG Foundation|National Cancer Institute (NCI) |
Mixed Mesodermal (Mullerian) Tumor|Ovarian Carcinosarcoma|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma|Stage I Ovarian Cancer AJCC v6 and v7|Stage IA Fallopian Tube Cancer AJCC v6 and v7|Stage IA Ovarian Cancer AJCC v6 and v7|Stage IA Uterine Sarcoma AJCC v7|Stage IB Fallopian Tube Cancer AJCC v6 and v7|Stage IB Ovarian Cancer AJCC v6 and v7|Stage IB Uterine Sarcoma AJCC v7|Stage IC Fallopian Tube Cancer AJCC v6 and v7|Stage IC Ovarian Cancer AJCC v6 and v7|Stage IC Uterine Sarcoma AJCC v7|Stage II Ovarian Cancer AJCC v6 and v7|Stage IIA Fallopian Tube Cancer AJCC v6 and v7|Stage IIA Ovarian Cancer AJCC V6 and v7|Stage IIA Uterine Sarcoma AJCC v7|Stage IIB Fallopian Tube Cancer AJCC v6 and v7|Stage IIB Ovarian Cancer AJCC v6 and v7|Stage IIB Uterine Sarcoma AJCC v7|Stage IIC Fallopian Tube Cancer AJCC v6 and v7|Stage IIC Ovarian Cancer AJCC v6 and v7|Stage IIIA Fallopian Tube Cancer AJCC v7|Stage IIIA Ovarian Cancer AJCC v6 and v7|Stage IIIA Primary Peritoneal Cancer AJCC v7|Stage IIIA Uterine Sarcoma AJCC v7|Stage IIIB Fallopian Tube Cancer AJCC v7|Stage IIIB Ovarian Cancer AJCC v6 and v7|Stage IIIB Primary Peritoneal Cancer AJCC v7|Stage IIIB Uterine Sarcoma AJCC v7|Stage IIIC Fallopian Tube Cancer AJCC v7|Stage IIIC Ovarian Cancer AJCC v6 and v7|Stage IIIC Primary Peritoneal Cancer AJCC v7|Stage IIIC Uterine Sarcoma AJCC v7|Stage IV Fallopian Tube Cancer AJCC v6 and v7|Stage IV Ovarian Cancer AJCC v6 and v7|Stage IV Primary Peritoneal Cancer AJCC v7|Stage IVA Uterine Sarcoma AJCC v7|Stage IVB Uterine Sarcoma AJCC v7|Uterine Carcinosarcoma
|
August 17, 2009 | Phase 3 |
NCT00467051 | Children´s Oncology Group|National Cancer Institute (NCI) |
Childhood Extracranial Germ Cell Tumor|Childhood Extragonadal Malignant Germ Cell Tumor|Childhood Malignant Ovarian Germ Cell Tumor|Childhood Malignant Testicular Germ Cell Tumor|Ovarian Choriocarcinoma|Ovarian Embryonal Carcinoma|Ovarian Yolk Sac Tumor|Recurrent Childhood Malignant Germ Cell Tumor|Recurrent Malignant Testicular Germ Cell Tumor|Recurrent Ovarian Germ Cell Tumor|Testicular Choriocarcinoma|Testicular Embryonal Carcinoma|Testicular Mixed Choriocarcinoma and Embryonal Carcinoma|Testicular Mixed Choriocarcinoma and Yolk Sac Tumor|Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor|Testicular Yolk Sac Tumor
|
November 5, 2007 | Phase 2 |
NCT00470366 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) |
Brain and Central Nervous System Tumors|Extragonadal Germ Cell Tumor|Ovarian Cancer|Teratoma|Testicular Germ Cell Tumor
|
March 2007 | Phase 2 |
NCT00002697 | Memorial Sloan Kettering Cancer Center |
Lymphoma
|
September 1995 | Phase 2 |
NCT00878254 | University of Miami |
Mantle-Cell Lymphoma
|
March 25, 2009 | Phase 2 |
NCT00003052 | European Organisation for Research and Treatment of Cancer - EORTC|The European Society for Hyperthermic Oncology|National Cancer Institute (NCI) |
Sarcoma
|
July 1997 | Phase 3 |
NCT00278278 | Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany|National Cancer Institute (NCI) |
Brain and Central Nervous System Tumors
|
September 2003 | Phase 3 |
NCT00006734 | Children´s Oncology Group|National Cancer Institute (NCI)|Southwest Oncology Group |
Sarcoma
|
May 2001 | Phase 3 |
NCT03034304 | SYZ Cell Therapy Co.. |
Advanced Solid Tumors
|
January 2017 | Phase 1 |
NCT00002822 | Medical Research Council|National Cancer Institute (NCI) |
Lung Cancer
|
March 1996 | Phase 3 |
NCT00880542 | Jonsson Comprehensive Cancer Center |
Sarcoma
|
August 2008 | Phase 2 |
NCT00354107 | National Cancer Institute (NCI) |
Anaplastic Large Cell Lymphoma|Recurrent Childhood Anaplastic Large Cell Lymphoma
|
January 2007 | Phase 1|Phase 2 |
NCT04012827 | Sun Yat-sen University|Jiangsu HengRui Medicine Co., Ltd. |
Soft Tissue Sarcoma
|
August 20, 2019 | Phase 2 |
NCT00354744 | Children´s Oncology Group|National Cancer Institute (NCI) |
Sarcoma
|
July 2006 | Phase 3 |
NCT02544425 | Samsung Medical Center |
Extranodal NK-T-Cell Lymphoma
|
February 21, 2016 | Phase 2 |
NCT00002532 | Hannover Medical School|National Cancer Institute (NCI) |
Leukemia
|
January 1993 | Phase 2 |
NCT00003209 | European Organisation for Research and Treatment of Cancer - EORTC|Medical Research Council |
Cervical Cancer
|
December 1997 | Phase 3 |
NCT00790244 | Oslo University Hospital|Scandinavian Sarcoma Group |
Soft Tissue Sarcoma|Non Metastatic Disease
|
October 2007 | Phase 2 |
NCT00204646 | University Hospital Tuebingen |
Sarcoma, Soft Tissue
|
February 1999 | Phase 2 |
NCT00618813 | Children´s Oncology Group|National Cancer Institute (NCI) |
Ewing Sarcoma of Bone|Localized Ewing Sarcoma+Peripheral Primitive Neuroectodermal Tumor
|
March 2008 | Not Applicable |
NCT00080795 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) |
Bladder Cancer|Transitional Cell Cancer of the Renal Pelvis and Ureter|Urethral Cancer
|
July 2001 | Phase 2 |
NCT00025064 | Children´s Cancer and Leukaemia Group|National Cancer Institute (NCI) |
Lymphoma
|
January 2000 | Phase 2 |
NCT00002684 | Memorial Sloan Kettering Cancer Center |
Bladder Cancer|Urethral Cancer
|
May 1995 | Phase 2 |
NCT04199026 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) |
Metastatic Sarcoma|Recurrent Sarcoma|Resectable Sarcoma
|
January 31, 2023 | Early Phase 1 |
NCT00695032 | Institut Claudius Regaud |
Chemotherapeutic Agent Toxicity|Renal Toxicity|Unspecified Adult Solid Tumor, Protocol Specific
|
October 2007 | Not Applicable |
NCT00003860 | UNICANCER |
Lung Cancer
|
September 1998 | Phase 2 |
NCT00004887 | The Christie NHS Foundation Trust|National Cancer Institute (NCI) |
Lung Cancer
|
January 1999 | Phase 3 |
NCT00274950 | Children´s Cancer and Leukaemia Group|National Cancer Institute (NCI) |
Childhood Germ Cell Tumor|Extragonadal Germ Cell Tumor|Ovarian Cancer
|
May 2005 | Phase 3 |
NCT00004132 | Jonsson Comprehensive Cancer Center|National Cancer Institute (NCI) |
Drug+Agent Toxicity by Tissue+Organ|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Oral Complications|Radiation Toxicity
|
January 2000 | Phase 2 |
NCT00089544 | National Cancer Institute (NCI)|Radiation Therapy Oncology Group |
Recurrent Adult Soft Tissue Sarcoma|Stage I Adult Soft Tissue Sarcoma AJCC v7|Stage II Adult Soft Tissue Sarcoma AJCC v7|Stage III Adult Soft Tissue Sarcoma AJCC v7
|
June 17, 2004 | Phase 2 |
NCT00020566 | University of Leicester|National Cancer Institute (NCI)|Children´s Cancer and Leukaemia Group|Societe Francaise Oncologie Pediatrique|European Organisation for Research and Treatment of Cancer - EORTC|Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany|Gesellschaft fur Padiatrische Onkologie und Hamatologie - Austria|Swiss Group for Clinical Cancer Research|EBMT Solid Tumors Working Party|Children´s Oncology Group |
Sarcoma
|
February 2001 | Phase 3 |
NCT00002559 | Memorial Sloan Kettering Cancer Center |
Ovarian Cancer|Testicular Germ Cell Tumor
|
January 1994 | Phase 1|Phase 2 |
NCT00002974 | University of Wisconsin, Madison|National Cancer Institute (NCI) |
Sarcoma
|
July 1996 | Phase 2 |
NCT01710176 | Italian Sarcoma Group|French Sarcoma Group|Grupo Espanol de Investigacion en Sarcomas |
Localized High-risk Soft Tissue Sarcomas of the Extremities and Trunk Wall in Adults
|
June 1, 2011 | Phase 3 |
NCT00039195 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI)|Bristol-Myers Squibb|Genentech, Inc. |
Lymphoma
|
November 2006 | Phase 2 |
NCT03719105 | New York Medical College|University of Alabama at Birmingham |
NK-Cell Lymphoma|NK-Cell Leukemia|Peripheral T Cell Lymphoma
|
March 1, 2019 | Early Phase 1 |
NCT00189137 | University of Michigan Rogel Cancer Center |
Sarcoma, Soft Tissue
|
August 2004 | Phase 2 |
NCT00529503 | Seagen Inc.|Genentech, Inc. |
Lymphoma, Large B-Cell, Diffuse|Lymphoma, Non-Hodgkin
|
September 2007 | Phase 2 |
NCT00006373 | H. Lee Moffitt Cancer Center and Research Institute|National Cancer Institute (NCI) |
Lymphoma
|
February 2000 | Phase 2 |
NCT00379457 | European Paediatric Soft Tissue Sarcoma Study Group|Italian Association for Pediatric Hematology Oncology|Children´s Cancer and Leukaemia Group|Dutch Childhood Oncology Group|National Cancer Institute (NCI) |
Sarcoma
|
June 2006 | Phase 3 |
NCT02137096 | University of Florida |
Recurrent Nasopharynx Carcinoma
|
June 2014 | Phase 3 |
NCT00003240 | National Cancer Institute (NCI) |
Lung Cancer
|
October 1995 | Phase 3 |
NCT00003776 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) |
Sarcoma
|
December 1998 | Phase 2 |
NCT02732015 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) |
Locally Advanced Sarcoma
|
October 12, 2016 | Phase 2 |
NCT00006032 | H. Lee Moffitt Cancer Center and Research Institute|National Cancer Institute (NCI) |
Breast Cancer
|
March 2000 | Phase 2 |
NCT00274924 | Eastern Cooperative Oncology Group|National Cancer Institute (NCI) |
Lymphoma
|
April 2006 | Phase 2 |
NCT02408042 | Western Regional Medical Center |
Lymphoma|Hodgkin´s Lymphoma|Non-hodgkin´s Lymphoma
|
April 2015 | Phase 1|Phase 2 |
NCT02329080 | International Extranodal Lymphoma Study Group (IELSG) |
Diffuse Large B-cell Lymphoma
|
December 2014 | Phase 2 |
NCT03206671 | University Hospital Muenster|Deutsche Krebshilfe e.V., Bonn (Germany) |
Mature B-cell Non-Hodgkin Lymphoma
|
August 3, 2017 | Phase 3 |
NCT00432094 | Masonic Cancer Center, University of Minnesota |
Childhood Germ Cell Tumor|Ovarian Cancer|Teratoma
|
December 19, 2006 | Phase 2 |
NCT04044222 | Innovent Biologics (Suzhou) Co. Ltd. |
Classic Hodgkin´s Lymphoma
|
October 21, 2019 | Phase 3 |
NCT00003597 | Children´s Oncology Group|National Cancer Institute (NCI) |
Cancer
|
November 1998 | Phase 1 |
NCT00126191 | Dana-Farber Cancer Institute|Beth Israel Deaconess Medical Center|Brigham and Women´s Hospital |
Burkitt Lymphoma|Non-Hodgkins Lymphoma|Atypical Burkitt Lymphoma
|
July 2005 | Phase 2 |
NCT00006708 | Southwest Oncology Group|National Cancer Institute (NCI) |
Lymphoma
|
October 2000 | Phase 3 |
NCT01331590 | Washington University School of Medicine |
Precursor Cell Lymphoblastic Leukemia-Lymphoma
|
July 2011 | Early Phase 1 |
NCT04044378 | Peking University People´s Hospital|Peking University Shougang Hospital|Jiangsu HengRui Medicine Co., Ltd. |
Effect of Drugs|Progression|Pediatric Cancer
|
August 15, 2019 | Phase 1|Phase 2 |
NCT03805022 | Institut Bergonié|Novartis|Chugai Pharma France |
Non-metastatic Soft-tissue Sarcoma|Resectable
|
February 14, 2019 | Phase 3 |
NCT00086944 | National Cancer Institute (NCI) |
Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma
|
May 2004 | Phase 1|Phase 2 |
NCT02677116 | Eli Lilly and Company |
Neoplasm Metastasis
|
August 29, 2016 | Phase 1 |
NCT00003683 | UNICANCER |
Kidney Cancer
|
March 1998 | Phase 2 |
NCT00002854 | City of Hope Medical Center|National Cancer Institute (NCI) |
Cancer
|
December 1994 | Phase 1 |
NCT00040690 | Medical Research Council|National Cancer Institute (NCI) |
Leukemia|Lymphoma
|
November 2008 | Phase 2 |
NCT01464606 | Children´s Hospitals and Clinics of Minnesota |
Pleuropulmonary Blastoma
|
December 22, 2009 | Not Applicable |
NCT00283621 | M.D. Anderson Cancer Center|Amgen |
Sarcoma
|
June 2, 2003 | Not Applicable |
NCT02718482 | Italian Sarcoma Group |
OSTEOSARCOMA
|
April 6, 2016 | Phase 2 |
NCT00334867 | Children´s Oncology Group|National Cancer Institute (NCI) |
Sarcoma
|
December 2005 | Phase 3 |
NCT00423852 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) |
Brain and Central Nervous System Tumors|Extragonadal Germ Cell Tumor|Ovarian Cancer|Teratoma|Testicular Germ Cell Tumor
|
August 2006 | Phase 1|Phase 2 |
NCT02393157 | New York Medical College|Roswell Park Cancer Institute |
Non-Hodgkin Lymphoma|Burkitt Lymphoma|Diffuse Large B-Cell Lymphoma|Primary Mediastinal B-cell Lymphoma|CD20&addition; Lymphoblastic Lymphoma|Follicular Lymphoma, Grade III
|
February 2015 | Phase 2 |
NCT00003406 | Cancer Treatment Centers of America|National Cancer Institute (NCI) |
Chronic Myeloproliferative Disorders|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Precancerous+Nonmalignant Condition|Unspecified Adult Solid Tumor, Protocol Specific
|
October 1997 | Phase 1|Phase 2 |
NCT02305654 | Institute of Cancer Research, United Kingdom|National Cancer Institute (NCI)|ECOG-ACRIN Cancer Research Group|Canadian Cancer Trials Group |
Squamous Cell Carcinoma of the Penis, Usual Type
|
May 12, 2017 | Phase 3 |
NCT02441309 | University of Oxford|Millennium: The Takeda Oncology Company|National Institute for Health Research, United Kingdom|Oxford University Hospitals NHS Trust|European Commission |
Osteosarcoma
|
October 2014 | Phase 2 |
NCT00334854 | European Paediatric Soft Tissue Sarcoma Study Group|Italian Association for Pediatric Hematology Oncology|Cooperative Weichteilsarkom Studie|Children´s Cancer and Leukaemia Group|Dutch Childhood Oncology Group|National Cancer Institute (NCI) |
Childhood Malignant Fibrous Histiocytoma of Bone|Sarcoma
|
March 2006 | Phase 3 |
NCT05364424 | Hoffmann-La Roche |
Diffuse Large B-Cell Lymphoma (DLBCL)
|
November 4, 2022 | Phase 1 |
NCT02018861 | Incyte Corporation |
B-Cell Malignancies
|
September 22, 2016 | Phase 1|Phase 2 |
NCT02099188 | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano|Regione Lombardia |
Unresectable Sinonasal Tumors
|
November 2013 | Phase 2 |
NCT00652860 | Mayo Clinic|National Cancer Institute (NCI) |
Metastatic Cancer|Sarcoma
|
August 2001 | Phase 2 |
NCT00796120 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|PharmaMar |
Sarcoma
|
November 2008 | Phase 3 |
NCT01117441 | University Hospital Schleswig-Holstein|Deutsche Krebshilfe e.V., Bonn (Germany) |
Leukemia
|
June 2010 | Phase 3 |
NCT00003198 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) |
Unspecified Adult Solid Tumor, Protocol Specific
|
November 1997 | Phase 1 |
NCT00002643 | National Cancer Institute (NCI)|Children´s Cancer Group |
Neutropenia|Sarcoma
|
April 1995 | Phase 2 |
NCT02422563 | Charite University, Berlin, Germany |
Cervical Cancer
|
October 2015 | Phase 3 |
NCT00061893 | Children´s Oncology Group|National Cancer Institute (NCI) |
Sarcoma
|
April 2004 | Phase 2 |
NCT03349346 | Gilead Sciences |
Diffuse Large B-Cell Lymphoma|Mediastinal B-cell Lymphoma
|
June 2019 | Phase 1 |
NCT00005977 | Children´s Oncology Group|National Cancer Institute (NCI) |
Leukemia|Lymphoma
|
September 2000 | Phase 3 |
NCT02324296 | Arcispedale Santa Maria Nuova-IRCCS |
Small Cell Lung Cancer
|
December 1998 | |
NCT00410488 | M.D. Anderson Cancer Center|Eisai Inc. |
Sarcoma|Nausea|Vomiting
|
December 2006 | Not Applicable |
NCT02703272 | Janssen Research & Development, LLC|Pharmacyclics LLC. |
Lymphoma, Non-Hodgkin
|
July 1, 2016 | Phase 3 |
NCT00526318 | Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany|National Cancer Institute (NCI) |
Neuroblastoma
|
January 2007 | Not Applicable |
NCT00742924 | Children´s Oncology Group|National Cancer Institute (NCI) |
Sarcoma
|
August 2008 | Phase 1 |
NCT04833114 | GWT-TUD GmbH|Hoffmann-La Roche |
Relapsed Diffuse Large B-cell Lymphoma|Refractory Diffuse Large B-Cell Lymphoma
|
April 30, 2021 | Phase 3 |
NCT01156883 | Gruppo Italiano Malattie EMatologiche dell´Adulto |
Leukemia
|
April 2010 | Not Applicable |
NCT00720109 | National Cancer Institute (NCI) |
Acute Lymphoblastic Leukemia|Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1|Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
|
July 14, 2008 | Phase 2|Phase 3 |
NCT00199069 | Johann Wolfgang Goethe University Hospital|Deutsche Krebshilfe e.V., Bonn (Germany) |
Adult Acute Lymphocytic Leukemia
|
April 1993 | Phase 4 |
NCT03367143 | Ruijin Hospital |
Diffuse Large B-Cell Lymphoma Refractory
|
December 2016 | Phase 2 |
NCT01258634 | University of Chicago |
Osteosarcoma|Lung Metastases
|
July 2010 | Phase 1 |
NCT00484601 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
Refractory Nasopharyngeal Carcinoma
|
April 15, 2004 | Phase 2 |
NCT01864109 | Memorial Sloan Kettering Cancer Center |
Newly Diagnosed Ewing Sarcoma
|
May 2013 | Phase 2 |
NCT00002982 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) |
Lymphoma
|
January 1997 | Phase 2 |
NCT03440567 | City of Hope Medical Center|National Cancer Institute (NCI) |
Recurrent Diffuse Large B-Cell Lymphoma|Recurrent Mantle Cell Lymphoma|Refractory Diffuse Large B-Cell Lymphoma|Refractory Mantle Cell Lymphoma|Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma
|
April 2, 2018 | Phase 1 |
NCT00002531 | Johann Wolfgang Goethe University Hospital|National Cancer Institute (NCI) |
Leukemia
|
January 1993 | Phase 2 |
NCT03514381 | Institut Claudius Regaud |
Soft Tissue Sarcoma
|
May 18, 2018 | Phase 4 |
NCT04356872 | Fudan University|Zhejiang Cancer Hospital|Tongji Hospital|Xijing Hospital|Shanghai Zhongshan Hospital |
Sarcoma, Soft Tissue
|
April 8, 2020 | Phase 2 |
NCT02227199 | University of Washington|National Cancer Institute (NCI)|Seagen Inc. |
Recurrent Hodgkin Lymphoma|Refractory Hodgkin Lymphoma
|
October 10, 2014 | Phase 1|Phase 2 |
NCT00346125 | Masonic Cancer Center, University of Minnesota |
Sarcoma
|
April 2006 | Not Applicable |
NCT00004186 | University of Alabama at Birmingham|National Cancer Institute (NCI) |
Lung Cancer
|
December 1996 | Phase 1|Phase 2 |
NCT00936936 | M.D. Anderson Cancer Center |
Testicular Cancer
|
June 2, 2009 | Phase 2 |
NCT02686346 | The Lymphoma Academic Research Organisation|Millennium Pharmaceuticals, Inc. |
Hodgkin Disease
|
March 2016 | Phase 1|Phase 2 |
NCT05533775 | Hoffmann-La Roche |
Mature B-Cell Non-Hodgkin Lymphoma
|
November 30, 2022 | Phase 1|Phase 2 |
NCT00002802 | Children´s Hospital Medical Center, Cincinnati|National Cancer Institute (NCI) |
Neuroblastoma
|
July 1990 | Phase 3 |
NCT00003941 | European Organisation for Research and Treatment of Cancer - EORTC |
Mediastinal Cancer|Metastatic Cancer|Testicular Germ Cell Tumor
|
April 1999 | Phase 3 |
NCT04947501 | Memorial Sloan Kettering Cancer Center |
Neuroblastoma|Pediatric Cancer
|
June 22, 2021 | Early Phase 1 |
NCT02784015 | Samsung Medical Center |
Unresectable Localized Soft Tissue Sarcoma
|
May 2016 | Phase 2 |
NCT00023998 | National Cancer Institute (NCI) |
Metastatic Osteosarcoma
|
July 2001 | Phase 2 |
NCT02180867 | National Cancer Institute (NCI) |
Alveolar Soft Part Sarcoma|Angiomatoid Fibrous Histiocytoma|Atypical Fibroxanthoma|Clear Cell Sarcoma of Soft Tissue|Epithelioid Malignant Peripheral Nerve Sheath Tumor|Epithelioid Sarcoma|Extraskeletal Myxoid Chondrosarcoma|Extraskeletal Osteosarcoma|Fibrohistiocytic Neoplasm|Fibrosarcoma|Inflammatory Myofibroblastic Tumor|Intimal Sarcoma|Leiomyosarcoma|Liposarcoma|Liver Embryonal Sarcoma|Low Grade Fibromyxoid Sarcoma|Low Grade Myofibroblastic Sarcoma|Malignant Cutaneous Granular Cell Tumor|Malignant Peripheral Nerve Sheath Tumor|Malignant Triton Tumor|Mesenchymal Chondrosarcoma|Myxofibrosarcoma|Myxoid Chondrosarcoma|Myxoinflammatory Fibroblastic Sarcoma|Nerve Sheath Neoplasm|PEComa|Pericytic Neoplasm|Plexiform Fibrohistiocytic Tumor|Sclerosing Epithelioid Fibrosarcoma|Skin Glomus Tumor|Stage IB Soft Tissue Sarcoma AJCC v7|Stage IIB Soft Tissue Sarcoma AJCC v7|Stage III Soft Tissue Sarcoma AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7|Synovial Sarcoma|Undifferentiated High Grade Pleomorphic Sarcoma of Bone
|
July 11, 2014 | Phase 2|Phase 3 |
NCT03360760 | Peking University People´s Hospital |
Osteosarcoma of Pelvis
|
August 1, 2018 | Not Applicable |
NCT00030784 | European Organisation for Research and Treatment of Cancer - EORTC |
Sarcoma
|
November 2001 | Phase 1 |
NCT03283696 | Eli Lilly and Company |
Soft Tissue Sarcoma
|
October 18, 2017 | Phase 1 |
NCT00039130 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) |
Leukemia|Lymphoma
|
May 2002 | Phase 2 |
NCT04154189 | Eisai Inc.|Merck Sharp & Dohme LLC |
Osteosarcoma
|
March 23, 2020 | Phase 2 |
NCT00003086 | Louisiana State University Health Sciences Center Shreveport |
Breast Cancer
|
March 1997 | Phase 1|Phase 2 |
NCT02808247 | European Organisation for Research and Treatment of Cancer - EORTC|Boehringer Ingelheim |
Sarcoma, Soft Tissue
|
July 7, 2017 | Phase 2 |
NCT02235701 | ImmunityBio, Inc. |
Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma
|
September 2, 2014 | Phase 1|Phase 2 |
NCT00502892 | M.D. Anderson Cancer Center |
Solid Tumors
|
August 2004 | Phase 1 |
NCT00003937 | Children´s Oncology Group|National Cancer Institute (NCI) |
Cardiac Toxicity|Sarcoma
|
September 1999 | Phase 3 |
NCT01871766 | St. Jude Children´s Research Hospital |
Rhabdomyosarcoma
|
December 4, 2013 | Phase 2 |
NCT03736616 | Swedish Medical Center|Acerta Pharma BV |
Diffuse Large B Cell Lymphoma
|
August 16, 2019 | Phase 2 |
NCT00017160 | Radiation Therapy Oncology Group|National Cancer Institute (NCI) |
Stage III Adult Soft Tissue Sarcoma|Recurrent Adult Soft Tissue Sarcoma|Stage IVA Adult Soft Tissue Sarcoma|Stage IIB Adult Soft Tissue Sarcoma|Stage IIC Adult Soft Tissue Sarcoma
|
Phase 2 | |
NCT01172912 | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano|National Cancer Institute (NCI) |
Brain and Central Nervous System Tumors|Extragonadal Germ Cell Tumor|Testicular Germ Cell Tumor
|
October 2010 | Phase 2 |
NCT00022737 | National Cancer Institute (NCI) |
Childhood Acute Lymphoblastic Leukemia in Remission|Recurrent Childhood Acute Lymphoblastic Leukemia
|
October 2002 | Phase 3 |
NCT00199095 | Johann Wolfgang Goethe University Hospital |
Adult Acute Lymphocytic Leukemia
|
February 1997 | Phase 4 |
NCT00669812 | Cancer Research UK|National Cancer Institute (NCI) |
Lymphoma|Small Intestine Cancer
|
February 2008 | Phase 2 |
NCT03077828 | Northwestern University|Merck Sharp & Dohme LLC|National Cancer Institute (NCI) |
Lymphocyte-Rich Classical Hodgkin Lymphoma|Recurrent Lymphocyte-Depleted Classical Hodgkin Lymphoma|Recurrent Mixed Cellularity Classical Hodgkin Lymphoma|Recurrent Nodular Sclerosis Classical Hodgkin Lymphoma|Refractory Lymphocyte-Depleted Classical Hodgkin Lymphoma|Refractory Mixed Cellularity Classical Hodgkin Lymphoma|Refractory Nodular Sclerosis Classical Hodgkin Lymphoma
|
April 21, 2017 | Phase 2 |
NCT00601718 | University of Washington|National Cancer Institute (NCI) |
Adult Nasal Type Extranodal NK+T-cell Lymphoma|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Contiguous Stage II Mantle Cell Lymphoma|Cutaneous B-cell Non-Hodgkin Lymphoma|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Nodal Marginal Zone B-cell Lymphoma|Noncontiguous Stage II Mantle Cell Lymphoma|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides+Sezary Syndrome|Recurrent Small Lymphocytic Lymphoma|Splenic Marginal Zone Lymphoma|Stage I Cutaneous T-cell Non-Hodgkin Lymphoma|Stage I Mantle Cell Lymphoma|Stage I Mycosis Fungoides+Sezary Syndrome|Stage II Cutaneous T-cell Non-Hodgkin Lymphoma|Stage II Mycosis Fungoides+Sezary Syndrome|Stage III Cutaneous T-cell Non-Hodgkin Lymphoma|Stage III Mantle Cell Lymphoma|Stage III Mycosis Fungoides+Sezary Syndrome|Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma|Stage IV Mantle Cell Lymphoma|Stage IV Mycosis Fungoides+Sezary Syndrome|Waldenström Macroglobulinemia
|
December 2007 | Phase 1|Phase 2 |
NCT00689845 | University Hospital Southampton NHS Foundation Trust|National Cancer Institute (NCI) |
Lymphoma
|
June 2007 | Not Applicable |
NCT00003212 | European Organisation for Research and Treatment of Cancer - EORTC |
Sarcoma
|
January 1998 | Phase 3 |
NCT00104676 | UNICANCER |
Extragonadal Germ Cell Tumor|Teratoma|Testicular Germ Cell Tumor
|
November 26, 2003 | Phase 3 |
NCT01590732 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) |
Mycosis Fungoides|Recurrent Anaplastic Large Cell Lymphoma|Recurrent Angioimmunoblastic T-Cell Lymphoma|Recurrent Enteropathy-Associated T-Cell Lymphoma|Recurrent Hepatosplenic T-Cell Lymphoma|Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified|Refractory Anaplastic Large Cell Lymphoma|Refractory Angioimmunoblastic T-Cell Lymphoma|Refractory Enteropathy-Associated T-Cell Lymphoma|Refractory Hepatosplenic T-Cell Lymphoma|Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified
|
October 29, 2012 | Phase 1 |
NCT00267046 | M.D. Anderson Cancer Center |
Sarcoma|Oral Mucositis
|
December 2005 | Phase 2 |
NCT01784107 | Gachon University Gil Medical Center |
Small Cell Lung Cancer
|
July 2011 | Phase 1|Phase 2 |
Solid
Room temperature in continental US; may vary elsewhere.
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
DMSO : ≥ 50 mg/mL ( 191.50 mM )
* "≥" means soluble, but saturation unknown.
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 3.8301 mL | 19.1505 mL | 38.3010 mL |
5 mM | 0.7660 mL | 3.8301 mL | 7.6602 mL |
10 mM | 0.3830 mL | 1.9150 mL | 3.8301 mL |
Add each solvent one by one: 0.5% CMC-Na /saline water
Solubility: 25 mg/mL (95.75 mM); Clear solution; Need ultrasonic
Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)
Solubility: ≥ 2.5 mg/mL (9.58 mM); Clear solution
Add each solvent one by one: 10% DMSO >> 90% corn oil
Solubility: ≥ 2.5 mg/mL (9.58 mM); Clear solution